Loading...

DaVita Inc. Peer Comparison

Metric Value Ranking
Market Cap $14.1 Billion 2/13 HCA
$84.7B
DVA
$14.1B
THC
$12.0B
UHS
$11.8B
EHC
$9.9B
ENSG
$7.2B
OPCH
$5.4B
ACHC
$3.8B
SGRY
$3.3B
AMED
$3.0B
USPH
$1.3B
AMN
$911.9M
CYH
$453.0M
Gross Margin 34% 8/13 ACHC
96%
HCA
85%
AMED
77%
UHS
72%
EHC
46%
THC
35%
USPH
35%
DVA
34%
AMN
31%
SGRY
23%
CYH
21%
OPCH
20%
ENSG
15%
Profit Margin 7% 4/13 THC
13%
EHC
9%
ACHC
8%
DVA
7%
HCA
7%
UHS
7%
AMED
7%
ENSG
7%
OPCH
4%
USPH
3%
AMN
1%
SGRY
-4%
CYH
-13%
EBITDA margin 21% 1/13 DVA
21%
ACHC
20%
HCA
19%
EHC
19%
UHS
13%
USPH
11%
ENSG
11%
THC
9%
OPCH
8%
AMED
4%
AMN
3%
CYH
-4%
SGRY
-5%
Quarterly Revenue $3.3 Billion 4/13 HCA
$17.5B
THC
$5.1B
UHS
$4.0B
DVA
$3.3B
CYH
$3.1B
EHC
$1.4B
OPCH
$1.3B
ENSG
$1.1B
ACHC
$815.6M
SGRY
$770.4M
AMN
$687.5M
AMED
$587.7M
USPH
$168.0M
Quarterly Earnings $214.7 Million 4/13 HCA
$1.3B
THC
$681.0M
UHS
$258.7M
DVA
$214.7M
EHC
$120.9M
ENSG
$78.4M
ACHC
$68.1M
OPCH
$53.9M
AMED
$41.5M
AMN
$7.0M
USPH
$5.5M
SGRY
-$31.7M
CYH
-$391.0M
Quarterly Free Cash Flow $671.4 Million 3/13 HCA
$2.3B
THC
$839.0M
DVA
$671.4M
OPCH
$150.7M
AMED
$104.2M
ENSG
$89.0M
UHS
$81.9M
AMN
$47.4M
SGRY
$45.0M
USPH
$19.1M
CYH
-$3.0M
ACHC
-$27.1M
EHC
-$0
Trailing 4 Quarters Revenue $12.7 Billion 4/13 HCA
$69.6B
THC
$21.0B
UHS
$15.4B
DVA
$12.7B
CYH
$12.6B
EHC
$5.4B
OPCH
$4.8B
ENSG
$4.1B
ACHC
$3.1B
AMN
$3.1B
SGRY
$3.0B
AMED
$2.3B
USPH
$622.4M
Trailing 4 Quarters Earnings $827.7 Million 4/13 HCA
$17.5B
THC
$5.1B
UHS
$4.0B
DVA
$3.3B
CYH
$3.1B
EHC
$1.4B
OPCH
$1.3B
ENSG
$1.1B
ACHC
$815.6M
SGRY
$770.4M
AMN
$687.5M
AMED
$587.7M
USPH
$168.0M
Quarterly Earnings Growth -13% 9/13 THC
574%
ACHC
131%
AMED
60%
UHS
55%
EHC
38%
ENSG
23%
HCA
18%
OPCH
-4%
DVA
-13%
USPH
-21%
AMN
-87%
SGRY
-188%
CYH
-330%
Annual Earnings Growth 6% 7/13 ACHC
34630%
THC
726%
AMED
159%
UHS
51%
EHC
33%
HCA
27%
DVA
6%
ENSG
-6%
USPH
-36%
OPCH
-48%
AMN
-78%
CYH
-94%
SGRY
-101%
Quarterly Revenue Growth 5% 10/13 OPCH
17%
ENSG
15%
SGRY
14%
EHC
13%
USPH
12%
UHS
11%
ACHC
9%
HCA
8%
AMED
6%
DVA
5%
THC
1%
CYH
0%
AMN
-19%
Annual Revenue Growth 4% 9/13 SGRY
12%
OPCH
11%
EHC
10%
ENSG
10%
HCA
9%
UHS
9%
ACHC
6%
AMED
5%
DVA
4%
THC
3%
USPH
3%
CYH
1%
AMN
-20%
Cash On Hand $1.1 Billion 3/13 THC
$4.1B
HCA
$2.9B
DVA
$1.1B
ENSG
$532.1M
OPCH
$483.0M
AMED
$245.5M
SGRY
$221.8M
USPH
$117.0M
UHS
$106.1M
EHC
$85.4M
ACHC
$82.1M
CYH
$33.0M
AMN
$30.6M
Short Term Debt $296.3 Million 2/13 HCA
$4.7B
DVA
$296.3M
EHC
$164.9M
CYH
$133.0M
UHS
$111.2M
SGRY
$97.3M
THC
$95.0M
USPH
$79.3M
ACHC
$71.7M
AMED
$63.9M
OPCH
$6.5M
ENSG
$4.1M
AMN
-$0
Long Term Debt $9.3 Billion 4/13 HCA
$38.3B
THC
$12.8B
CYH
$12.0B
DVA
$9.3B
UHS
$5.0B
SGRY
$3.4B
ACHC
$1.8B
OPCH
$1.1B
AMN
$845.6M
AMED
$404.6M
EHC
$189.7M
USPH
$154.5M
ENSG
$142.6M
PE 17.04 7/13 USPH
64.75
ENSG
30.20
OPCH
25.96
AMED
23.80
EHC
21.67
AMN
17.19
DVA
17.04
HCA
14.28
ACHC
13.66
UHS
11.52
THC
3.09
CYH
-1.00
SGRY
-1.00
PS 1.11 8/13 USPH
2.06
EHC
1.84
ENSG
1.78
AMED
1.31
ACHC
1.23
HCA
1.22
OPCH
1.14
DVA
1.11
SGRY
1.10
UHS
0.77
THC
0.57
AMN
0.30
CYH
0.04
PB 6.35 2/13 HCA
107.73
DVA
6.35
ENSG
4.14
OPCH
3.80
EHC
3.47
AMED
2.53
USPH
1.92
UHS
1.77
SGRY
1.73
THC
1.49
ACHC
1.22
AMN
1.02
CYH
0.00
PC 13.17 9/13 EHC
115.65
UHS
111.46
ACHC
46.68
AMN
29.85
HCA
29.32
SGRY
14.76
CYH
13.73
ENSG
13.62
DVA
13.17
AMED
12.37
OPCH
11.22
USPH
10.98
THC
2.93
Liabilities to Equity 39.52 1/13 DVA
39.52
THC
5.55
SGRY
2.97
AMN
2.00
ENSG
1.65
OPCH
1.40
EHC
1.32
UHS
1.15
ACHC
0.90
AMED
0.82
USPH
0.74
CYH
0.00
HCA
0.00
ROA 0.05 7/13 THC
13%
HCA
10%
UHS
7%
EHC
7%
AMED
6%
OPCH
6%
DVA
5%
ACHC
5%
ENSG
5%
AMN
2%
USPH
2%
SGRY
0%
CYH
-3%
ROE 2.14 1/13 DVA
214%
THC
101%
CYH
31%
EHC
16%
UHS
15%
OPCH
15%
ENSG
14%
AMED
11%
ACHC
9%
AMN
6%
USPH
4%
SGRY
0%
HCA
-272%
Current Ratio 1.15 11/13 USPH
2.87
AMED
2.28
ACHC
2.15
UHS
1.87
EHC
1.77
OPCH
1.71
ENSG
1.61
AMN
1.50
THC
1.38
SGRY
1.34
DVA
1.15
HCA
1.01
CYH
0.92
Quick Ratio 0.07 6/13 USPH
64.75
ENSG
30.20
OPCH
25.96
AMED
23.80
EHC
21.67
AMN
17.19
DVA
17.04
HCA
14.28
ACHC
13.66
UHS
11.52
THC
3.09
CYH
-1.00
SGRY
-1.00
Long Term Debt to Equity 23.95 1/13 DVA}
23.95
THC}
3.33
SGRY}
1.78
AMN}
0.95
OPCH}
0.77
UHS}
0.75
ACHC}
0.60
AMED}
0.35
USPH}
0.32
ENSG}
0.08
EHC}
0.07
CYH}
-9.44
HCA}
-17.54
Debt to Equity 24.71 1/13 DVA
24.71
THC
3.36
SGRY
1.83
AMN
0.95
OPCH
0.78
UHS
0.76
ACHC
0.62
USPH
0.53
AMED
0.41
EHC
0.13
ENSG
0.08
CYH
-9.55
HCA
-19.69
Burn Rate 4.66 2/13 USPH
5.71
DVA
4.66
ACHC
3.74
HCA
2.02
SGRY
1.16
AMN
1.14
CYH
0.04
EHC
-1.18
UHS
-3.41
ENSG
-7.42
AMED
-26.41
THC
-28.00
OPCH
-60.20
Cash to Cap 0.08 4/13 THC
0.34
USPH
0.09
OPCH
0.09
DVA
0.08
AMED
0.08
CYH
0.07
SGRY
0.07
ENSG
0.07
HCA
0.03
AMN
0.03
ACHC
0.02
UHS
0.01
EHC
0.01
CCR 3.13 3/13 AMN
6.79
USPH
3.45
DVA
3.13
OPCH
2.80
AMED
2.51
HCA
1.83
THC
1.23
ENSG
1.14
UHS
0.32
CYH
0.01
ACHC
-0.40
SGRY
-1.42
EHC
EV to EBITDA 32.50 10/13 AMED}
125.37
AMN}
77.61
USPH}
75.87
OPCH}
59.83
ENSG}
56.16
THC}
46.48
HCA}
38.23
EHC}
37.65
ACHC}
33.88
DVA}
32.50
UHS}
31.83
CYH}
-102.85
SGRY}
-181.37
EV to Revenue 1.78 6/13 USPH
2.28
SGRY
2.19
EHC
1.89
ACHC
1.80
HCA
1.79
DVA
1.78
ENSG
1.68
AMED
1.40
OPCH
1.27
UHS
1.09
CYH
1.00
THC
0.99
AMN
0.56